Variant VWD phenotype probability by LDA
| Subject ID . | Nonvariant . | Type 1C . | Type 2A . | Type 2B . | Type 2M . | Type 2N . |
|---|---|---|---|---|---|---|
| IN0270 | 0% | 5.4% | 94.6% | 0% | 0.01% | 0% |
| PB0169 | 7.3% | 92.5% | 0.08% | 0% | 0.13% | 0% |
| AT0003 | 0% | 0% | 0% | 100% | 0% | 0% |
| MK0260 | 0.57% | 2.1% | 1.8% | 0% | 95.5% | 0% |
| MK0039 | 1.2% | 2.5% | 0% | 0% | 0% | 96.3% |
| Subject ID . | Nonvariant . | Type 1C . | Type 2A . | Type 2B . | Type 2M . | Type 2N . |
|---|---|---|---|---|---|---|
| IN0270 | 0% | 5.4% | 94.6% | 0% | 0.01% | 0% |
| PB0169 | 7.3% | 92.5% | 0.08% | 0% | 0.13% | 0% |
| AT0003 | 0% | 0% | 0% | 100% | 0% | 0% |
| MK0260 | 0.57% | 2.1% | 1.8% | 0% | 95.5% | 0% |
| MK0039 | 1.2% | 2.5% | 0% | 0% | 0% | 96.3% |
Representative VWD phenotype probabilities (complete study cohort probability data available in the supplemental Data). Bolded percentage indicates ZPMCB-VWD confirmed diagnosis.